Abstract
To investigate the relationship between plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) activity and incidence of resistant hypertension (RH). This was a cross-sectional research. In essential, it was an observational design and collecting data on a population at a single point in time to evaluate the associations of studied variables. Totally 208 patients with arterial hypertension were enrolled. Baseline characteristics were collected and fasting venous blood were drawn for plasma Lp-PLA2 activity assessment. Twenty-four hour ambulatory blood pressure ambulatory (ABPM) was performed to diagnose RH. Initially, based on ABPM examination, all participants were divided into two groups, namely RH group and without RH group. And thereafter, in order to evaluate the effects of Lp-PLA2 activity on blood pressure, all participants were divided into low (< 225 nm/min/ml) and high (≥ 225 nm/min/ml) Lp-PLA2 activity groups based on the cut-off value of Lp-PLA2 activity. Comparisons were conducted between groups. Forty two patients were diagnosed as RH. Compared to patients without RH, patients with RH were more elderly, had more males, smokers, longer duration of hypertension, higher plasma C-reactive protein (CRP) level and Lp-...Continue Reading
References
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Piero O BonettiAmir Lerman
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Andrew Zalewski, Colin Macphee
Apr 13, 2005·Atherosclerosis. Supplements·Christie M Ballantyne, Vijay Nambi
Sep 28, 2005·Nature Clinical Practice. Cardiovascular Medicine·Muriel J Caslake, Chris J Packard
Jul 20, 2006·Preventive Cardiology·Richard B LanmanJoseph P McConnell
Feb 27, 2008·Circulation·Guoyong LiGary V Desir
Jun 25, 2008·Circulation·David A CalhounUNKNOWN American Heart Association Professional Education Committee
Aug 10, 2011·Circulation·Brent M EganKeith C Ferdinand
Mar 2, 2012·Circulation·Eduardo Pimenta, David A Calhoun
Feb 18, 2014·International Immunopharmacology·M A AbdelkrimM Y Mallem
Jul 26, 2014·Blood Pressure·Natália Ruggeri BarbaroHeitor Moreno
Sep 12, 2014·Journal of Human Hypertension·D J Hyman, V Pavlik
Nov 25, 2014·Seminars in Nephrology·Michel Burnier, Gregoire Wuerzner
Nov 25, 2014·Seminars in Nephrology·Angela Yee-Moon Wang
Jul 1, 2015·Journal of the American Heart Association·Anping CaiLiwen Li
Citations
Mar 22, 2018·Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne·Taraneh Faghihi LangroudiMohammadreza Naderian
Jun 22, 2018·Endocrine Journal·Guo-Hua WangLi-Zhou Sun
Feb 8, 2020·Toxicology Mechanisms and Methods·Izabela DobrzyńskaElżbieta Skrzydlewska
May 11, 2016·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Denisa CelovskaLudovit Gaspar
Apr 16, 2020·International Journal of Hypertension·Hye Jin YooJong Ho Lee
Jul 7, 2021·Acta Pharmacologica Sinica·Si-Lin LvMin Yang